Schedule 13G ownership disclosure
INSYS THERAPEUTICS INC
Security class unavailable · CUSIP: 45824V209
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,955,965
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001086318-16-000085
- Form type
- SC 13G
- Filer
- Insys Therapeutics, Inc.
- CIK
- CIK 1516479
- Filed
- Feb 16, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership